Errors in single gene may protect against heart disease

Rare mutations that shut down a single gene are linked to lower cholesterol levels and a 50 percent reduction in the risk of heart attack, according to new research led by Nathan Stitziel, MD, PhD, of the School of Medicine. The gene, called NPC1L1, is of interest because it is the target of the drug ezetimibe, often prescribed to lower cholesterol.

Wash U Expert: Supreme Court case against Affordable Care Act has no merit

The U.S. Supreme Court has agreed to hear a lawsuit targeting federal subsidies designed to help millions of Americans afford health insurance. The case is dubious on its merits, says Timothy D. McBride, PhD, professor at Washington University in St. Louis’ Brown School and a noted health economist, citing legal precedent as reason for allowing the subsidies to continue.
Older Stories